Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
Artiva Biotherapeutics, Inc. insider trades
Artiva Biotherapeutics, Inc.'s insiders made 22 buys and 26 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.
Insider trades
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Aslan Fred Director, Officer: Chief Executive Officer | Sale | 119,771 | USD 3.91 | US$469K | Nov 17, 2026 |
| Banerjee Subhashis Officer: Chief Medical Officer | Sale | 4,037 | USD 3.91 | US$15,792 | Nov 17, 2026 |
| Bush Jennifer Officer: COO, CLO, Compliance Officer | Sale | 19,217 | USD 3.91 | US$75,175 | Nov 17, 2026 |
| Horan Christopher Officer: Chief Tech Operations Officer | Sale | 20,546 | USD 3.91 | US$80,374 | Nov 17, 2026 |
| Miralles Gines Diego Officer: President & Head of R&D | Sale | 1,043 | USD 3.91 | US$4,080 | Nov 17, 2026 |
| Aslan Fred Director, Officer: Chief Executive Officer | Sale | 62,178 | USD 4.18 | US$260K | Nov 2, 2026 |
| Banerjee Subhashis Officer: Chief Medical Officer | Sale | 1,110 | USD 4.18 | US$4,641 | Nov 2, 2026 |
| Bush Jennifer Officer: COO, CLO, Compliance Officer | Sale | 8,439 | USD 4.18 | US$35,284 | Nov 2, 2026 |
| Horan Christopher Officer: Chief Tech Operations Officer | Sale | 10,423 | USD 4.18 | US$43,580 | Nov 2, 2026 |
| Aslan Fred Director, Officer: Chief Executive Officer | Sale | 23,463 | USD 7.20 | US$169K | Oct 6, 2026 |
| Aslan Fred Director, Officer: Chief Executive Officer | Sale | 61,696 | USD 6.84 | US$422K | Oct 5, 2026 |
| Banerjee Subhashis Officer: Chief Medical Officer | Sale | 1,099 | USD 6.84 | US$7,514 | Oct 5, 2026 |
| Bush Jennifer Officer: COO, CLO, Compliance Officer | Sale | 8,370 | USD 6.84 | US$57,227 | Oct 5, 2026 |
| Horan Christopher Officer: Chief Tech Operations Officer | Sale | 10,340 | USD 6.84 | US$70,697 | Oct 5, 2026 |
| Aslan Fred Director, Officer: Chief Executive Officer | Sale | 23,429 | USD 10.92 | US$256K | Sep 8, 2026 |
| Aslan Fred Director, Officer: Chief Executive Officer | Sale | 61,888 | USD 11.16 | US$691K | Sep 3, 2026 |
| Banerjee Subhashis Officer: Chief Medical Officer | Sale | 1,100 | USD 11.16 | US$12,276 | Sep 3, 2026 |
| Bush Jennifer Officer: COO, CLO, Compliance Officer | Sale | 8,391 | USD 11.16 | US$93,644 | Sep 3, 2026 |
| Horan Christopher Officer: Chief Tech Operations Officer | Sale | 10,366 | USD 11.16 | US$116K | Sep 3, 2026 |
| Banerjee Subhashis Officer: Chief Medical Officer | Sale | 8,222 | USD 12.01 | US$98,746 | Aug 27, 2026 |
| Banerjee Subhashis Officer: Chief Medical Officer | Sale | 429 | USD 12.00 | US$5,148 | Aug 18, 2026 |
| RA Capital Healthcare Fund LP Director, 10% owner | Buy | 24,944 | USD 9.93 | US$248K | Jul 31, 2026 |
| RA Capital Healthcare Fund LP Director, 10% owner | Buy | 20,824 | USD 9.99 | US$208K | Jul 29, 2026 |
| RA Capital Nexus Fund III, L.P. Director | Buy | 41,319 | USD 9.99 | US$413K | Jul 24, 2026 |
| Kolchinsky Peter Director, 10% owner | Buy | 59,880 | USD 9.96 | US$596K | Jul 23, 2026 |
| Kolchinsky Peter Director, 10% owner | Buy | 84,124 | USD 9.93 | US$835K | Jul 22, 2026 |
| Kolchinsky Peter Director, 10% owner | Buy | 120,582 | USD 9.55 | US$1.15M | Jul 21, 2026 |
| RA Capital Healthcare Fund LP Director, 10% owner | Buy | 7,882 | USD 8.95 | US$70,544 | Jul 17, 2026 |
| RA Capital Healthcare Fund LP Director, 10% owner | Buy | 152,472 | USD 8.93 | US$1.36M | Jul 16, 2026 |
| RA Capital Nexus Fund, L.P. Director | Buy | 6,522 | USD 8.94 | US$58,307 | Jul 13, 2026 |
| Shah Rajeev M. Director, 10% owner | Buy | 6,552 | USD 8.94 | US$58,575 | Jul 13, 2026 |
| Shah Rajeev M. Director, 10% owner | Buy | 15,102 | USD 8.97 | US$135K | Jul 10, 2026 |
| Ra Capital Management, L.P. Director, 10% owner | Buy | 1,876 | USD 8.98 | US$16,846 | Jun 26, 2026 |
| Ra Capital Management, L.P. Director, 10% owner | Buy | 31,000 | USD 8.88 | US$275K | Jun 25, 2026 |
| Kolchinsky Peter Director, 10% owner | Buy | 124,893 | USD 8.89 | US$1.11M | Jun 16, 2026 |
| Kolchinsky Peter Director, 10% owner | Buy | 15,414 | USD 8.99 | US$139K | Jun 15, 2026 |
| Kolchinsky Peter Director, 10% owner | Buy | 391,019 | USD 8.57 | US$3.35M | Jun 12, 2026 |
| RA Capital Nexus Fund, L.P. Director | Buy | 548,580 | USD 7.91 | US$4.34M | Jun 11, 2026 |
| RA Capital Nexus Fund, L.P. Director | Buy | 103 | USD 7.00 | US$721 | Jun 10, 2026 |
| RA Capital Nexus Fund, L.P. Director | Buy | 479,039 | USD 6.91 | US$3.31M | Jun 9, 2026 |
| Aslan Fred Director, Officer: Chief Executive Officer | Sale | 27,116 | USD 9.01 | US$244K | May 19, 2026 |
| Banerjee Subhashis Officer: Chief Medical Officer | Sale | 7,037 | USD 9.01 | US$63,403 | May 19, 2026 |
| Bush Jennifer Officer: COO, CLO, Compliance Officer | Sale | 8,790 | USD 9.01 | US$79,198 | May 19, 2026 |
| Horan Christopher Officer: Chief Tech Operations Officer | Sale | 7,002 | USD 9.01 | US$63,088 | May 19, 2026 |
| Raymon Heather Officer: SVP, Research and Development | Sale | 3,095 | USD 9.01 | US$27,886 | May 19, 2026 |
| GC Corp 10% owner | Buy | 1,085,069 | USD 11.52 | US$12.5M | May 11, 2026 |
| GC Corp 10% owner | Buy | 347,222 | USD 11.52 | US$4M | May 11, 2026 |
| RA Capital Nexus Fund III, L.P. Director | Buy | 6,510,416 | USD 11.52 | US$75M | May 11, 2026 |